Skip to main content

"We've detected that you're visiting from {0}. Would you like to switch languages for tailored content?"

->

Protecting incisions beyond the OR

Support your patients’ recovery with 3M™ Prevena™ Therapy incision management, to help protect and bolster the incision site, optimise the healing environment of the closed incision, and reduce surgical site complications.

View brochure
Prevena Restor™ BellaForm™ Incision Management System Patient can manage therapy at home
Prevena Therapy Proactive Risk Management Specialty areas Devices & dressings Recycling Prevena Contact us
On this page...
Prevena Therapy
Proactive Risk Management
Specialty areas
Devices & dressings
Recycling Prevena
Contact us

Proactively manage postoperative recovery

In today's healthcare landscape, where complex surgeries and patient comorbidities are prevalent, effective postoperative care is crucial to reduce extended hospital stays, readmissions and to improve overall patient outcomes. The Prevena Incision Management System is designed to proactively manage the environment of closed surgical incisions, such as superficial surgical site infections in Class I and Class II wounds* in patients at high risk for postoperative infections and incidence of seroma by maintaining a sealed environment with negative pressure therapy. This closed-incision negative pressure therapy (ciNPT) system provides:

  • Protection: Prevena dressings create a barrier against external contamination 
  • Negative pressure: Delivers continuous -125mmHg negative pressure therapy for up to 7 or 14 days
  • Incision support: Aids in keeping incision edges together, reducing lateral tension 
  • Fluid management: Removes fluids and infectious materials, helping to reduce edema 
  • Postoperative care: When used with legally marketed Prevena dressings for up to 14 days 3M™ Prevena™ 125 and 3M™ Prevena™ Plus 125 Therapy Units can help reduce the incidence of seromas and superficial surgical site infections (SSIs) in high-risk patients with Class I and II wounds

*The effectiveness of Prevena Therapy in reducing the incidence of SSIs and seroma in all surgical procedures and populations has not been demonstrated. Please see the full indications for use and limitations below.

The Prevena Restor Incision Management System advances original Prevena Therapy expanding NPWT coverage over closed incisions and the surrounding soft tissue to help postoperative recovery. The system introduces new features to improve patient care including:  

  • Expanded coverage: Larger dressing coverage area for the incision and adjacent soft tissue, protecting and bolstering the surgical site and optimising the healing environment  
  • Extended Therapy: The 3M™ Prevena™ Plus Therapy Unit provides 14 days of continuous NPWT; dressing changes required at 7 days  
  • Precision design: The dressing adapts to the patient’s body, allowing movement  
  • Versatile application: Intuitive, easy-to-use peel-and-place and flexible, user-customisable dressings available

Prevena Incision Management System: Mechanism of Action

Learn more

Evidence-based proactive risk management

To empower you to elevate care standards for ciNPT, Proactive Risk Management (PRM) with Prevena Therapy provides a systematic, evidence-backed approach. This clear, actionable model, supported by level 1, 2 and 3 clinical evidence, aids in assessing both procedural and patient risks, guiding the identification of those who would benefit most from Prevena Therapy and helping to reduce the costly complications of SSIs. 

SSIs account for 22 – 36% of all healthcare-associated infections1,2 and are a costly complication resulting in:

6X increased likelihood of 30-day readmission3

A graphical representation of a person and arrows continuously circling the person to indicate a strong brand experience. Dark green and teal positive color palette.

US$ 38,656 in additional costs4

Icon illustrating a stack of dollar bills

9.58 days longer stays in hospital4

An iconographic representation of a hospital bed. Dark green and teal positive color palette.

2.2X longer ICU stays3

Icon of a heart with an EKG line going through it.
To help reduce the risk of postoperative complications, Prevena Therapy has demonstrated significant improvement in key outcomes across multiple specialities5, including:

reduction in surgical site complications (SSCs)

46 studies; p<.001

Icon illustration 46%

reduction in surgical site infections (SSIs)

65 studies; p<.001

Icon illustration 47%

reduction in reoperations

40 studies; p<.001

Icon illustration 36%

reduction in readmissions

24 studies; p=.039

Icon illustration 23%

**The effectiveness of Prevena Therapy in reducing the incidence of SSIs and seroma in all surgical procedures and populations has not been demonstrated. See full indications for use and limitations at hcbgregulatory.3m.com.

Versatile options for your needs

Explore the wide selection of Prevena devices, dressings and kits – uniquely designed to meet the various needs of healthcare providers, surgical procedures and anatomical locations.

Prevena Therapy’s eco-friendly disposal program

Icon of a circle connecting a person, a building and leaves.

We appreciate your commitment to sustainability. Solventum's collaboration with Sharps® Compliance, Inc. ensures the eco-friendly disposal of your Prevena Therapy single-use negative pressure therapy units, free of charge.

 

To order a recycling box call 1300 524 822.

Contact a Solventum representative

We're here to help! Our team of representatives can provide you with information and resources to help you. Submit the form below to speak with a Solventum representative to learn more about your options.

Contact a representative

 

Looking for customer support? Visit the customer support page.

 

Note: Specific indications, limitations, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. This material is intended for healthcare professionals.

References :

  1. Zimlichman E, Henderson D, Tamir, et al. Health care-associated Infections a meta-analysis of costs and financial impact on the U.S. health care system. JAMA Interned.2013;173(22):20-46. 
  2. Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated Infections. N Engl JMed: 2014;370:1198-208. 
  3. Shepard J, Ward W, Milstone A, et al. Financial impact of surgical site infections on hospitals. The hospital management perspective. JAMA Surg. 2013;148(10):907-914.doi:10.1001/jamasurg.2013.2246 Published online August 21, 2013. 
  4. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA. 2003;290(14):1868-1874. 
  5. Cooper HJ, Singh DP, Gabriel A, Mantyh C, Silverman R, Griffin L. Closed Incision Negative Pressure Therapy Versus Standard of Care Over Closed Surgical Incisions in the Reduction of Surgical Site Complications: A Systematic Review and Meta-Analysis of Comparative Studies. Plastic and Reconstructive Surgery – Global Open. 2023 Mar 16;11(3):e4722.
  6. Berríos-Torres, S. I., Umscheid, C. A., Bratzler, D. W., Leas, B., Stone, E. C., Kelz, R. R., Reinke, C. E., Morgan, S., Solomkin, J. S., Mazuski, J. E., Dellinger, E. P., Itani, K. M., Berbari, E. F., Segreti, J., Parvizi, J., Blanchard, J., Allen, G., Kluytmans, J. A., Donlan, R., & Schecter, W. P. (2017). Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surgery, 152(8), 784. https://doi.org/10.1001/jamasurg.2017.0904
  7. Ban, K. A., Minei, J. P., Laronga, C., Harbrecht, B. G., Jensen, E. H., Fry, D. E., Itani, K. M. F., Dellinger, P. E., Ko, C. Y., & Duane, T. M. (2017). American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 update. Journal of the American College of Surgeons, 224(1), 59–74. https://doi.org/10.1016/j.jamcollsurg.2016.10.029

Product availability may vary by country. For specific details regarding availability in your region, please consult with a Solventum representative.

Please note that 3M Healthcare is now operating as Solventum. The products featured on this website, except Negative Pressure Wound Therapy and select Advance Wound Care products, are sponsored by KCI Medical New Zealand Unlimited (Suite 1701, Level 17, PwC Tower 15 Customs Street West Auckland Central, Auckland 1010 New Zealand), a wholly owned subsidiary of Solventum.

The Negative Pressure Wound Therapy products and select Advance Wound Care products are sponsored by: InterMed Medical Limited (71 Apollo Drive, Albany, Auckland 0632)